Standard Biotools (LAB) Gross Profit (2010 - 2026)

Standard Biotools (LAB) has 17 years of Gross Profit data on file, last reported at $11.3 million in Q1 2026.

• Quarterly Gross Profit rose 2.34% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.8 million (down 4.69% YoY) and the FY2025 annual result came in at $42.5 million, down 5.21% from the prior year.
• Gross Profit fell to $11.3 million in Q1 2026 per LAB's latest filing, from $11.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $24.6 million in Q1 2022 and bottomed at $4.4 million in Q2 2022.
• The 5-year median for Gross Profit is $11.3 million (2026), against an average of $12.5 million.
• The widest annual swing landed in 2022, when Gross Profit slumped 75.79%; it then soared 207.25% in 2023.
• Tracing LAB's Gross Profit over 5 years: stood at $11.2 million in 2022, then grew by 19.61% to $13.4 million in 2023, then decreased by 14.97% to $11.4 million in 2024, then gained by 0.22% to $11.4 million in 2025, then decreased by 0.65% to $11.3 million in 2026.
• Per Business Quant, the three latest LAB Gross Profit figures stand at $11.3 million (Q1 2026), $11.4 million (Q4 2025), and $9.5 million (Q3 2025).

Peer Comparison